Clint S. Schmidt

2.3k total citations
23 papers, 1.7k citations indexed

About

Clint S. Schmidt is a scholar working on Immunology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Clint S. Schmidt has authored 23 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 5 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Clint S. Schmidt's work include T-cell and B-cell Immunology (10 papers), Immune Cell Function and Interaction (9 papers) and Immunotherapy and Immune Responses (9 papers). Clint S. Schmidt is often cited by papers focused on T-cell and B-cell Immunology (10 papers), Immune Cell Function and Interaction (9 papers) and Immunotherapy and Immune Responses (9 papers). Clint S. Schmidt collaborates with scholars based in United States, Germany and India. Clint S. Schmidt's co-authors include Matthew F. Mescher, Julie Curtsinger, Marc K. Jenkins, Anna Mondino, Ross M. Kedl, Debra C. Lins, Javier O. Valenzuela, John E. Edwards, Ashraf S. Ibrahim and Scott G. Filler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Clint S. Schmidt

23 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clint S. Schmidt United States 18 1.2k 371 324 320 251 23 1.7k
Laurie Love-Homan United States 16 1.2k 1.0× 169 0.5× 487 1.5× 415 1.3× 172 0.7× 23 1.9k
Paula M. Chilton United States 24 1.3k 1.1× 191 0.5× 522 1.6× 425 1.3× 177 0.7× 54 2.2k
Mahmood Khan United Kingdom 26 1.6k 1.3× 420 1.1× 378 1.2× 232 0.7× 186 0.7× 43 2.5k
Pablo D. Becker Germany 26 811 0.7× 160 0.4× 419 1.3× 387 1.2× 200 0.8× 51 1.6k
Josette Fontaine France 29 1.6k 1.3× 220 0.6× 603 1.9× 329 1.0× 234 0.9× 45 2.6k
Brian S. Sheridan United States 27 1.7k 1.4× 254 0.7× 382 1.2× 555 1.7× 312 1.2× 54 2.4k
Sukanya Raghavan Sweden 28 1.2k 1.0× 168 0.5× 270 0.8× 195 0.6× 217 0.9× 49 1.9k
Elma Tchilian United Kingdom 29 1.3k 1.1× 736 2.0× 583 1.8× 699 2.2× 208 0.8× 85 2.3k
Shiki Takamura Japan 26 1.5k 1.2× 322 0.9× 353 1.1× 412 1.3× 367 1.5× 53 2.1k
Arash Shahangian United States 12 1.5k 1.3× 249 0.7× 639 2.0× 441 1.4× 231 0.9× 14 2.1k

Countries citing papers authored by Clint S. Schmidt

Since Specialization
Citations

This map shows the geographic impact of Clint S. Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clint S. Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clint S. Schmidt more than expected).

Fields of papers citing papers by Clint S. Schmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clint S. Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clint S. Schmidt. The network helps show where Clint S. Schmidt may publish in the future.

Co-authorship network of co-authors of Clint S. Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Clint S. Schmidt. A scholar is included among the top collaborators of Clint S. Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clint S. Schmidt. Clint S. Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wiltshire, Timothy D., Michael Deeds, Darcie J. Radel, et al.. (2021). Management of externally manufactured cell therapy products: the Mayo Clinic approach. Cytotherapy. 24(1). 19–26. 3 indexed citations
2.
Uppuluri, Priya, Shakti Singh, Abdullah Alqarihi, et al.. (2018). Human Anti-Als3p Antibodies Are Surrogate Markers of NDV-3A Vaccine Efficacy Against Recurrent Vulvovaginal Candidiasis. Frontiers in Immunology. 9. 1349–1349. 34 indexed citations
3.
Nyirjesy, Paul, et al.. (2016). 18: NDV-3A vaccine reduces the frequency of vaginitis in patients with recurrent vulvovaginal candidiasis. American Journal of Obstetrics and Gynecology. 215(6). S822–S822. 2 indexed citations
4.
Chan, Liana C., Scott G. Filler, Huiyuan Wang, et al.. (2015). Nonredundant Roles of Interleukin-17A (IL-17A) and IL-22 in Murine Host Defense against Cutaneous and Hematogenous Infection Due to Methicillin-Resistant Staphylococcus aureus. Infection and Immunity. 83(11). 4427–4437. 44 indexed citations
5.
Yeaman, Michael R., Scott G. Filler, Clint S. Schmidt, et al.. (2014). Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus. Frontiers in Immunology. 5. 463–463. 19 indexed citations
6.
Yeaman, Michael R., Scott G. Filler, Huiyuan Wang, et al.. (2014). Mechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection. Proceedings of the National Academy of Sciences. 111(51). E5555–63. 57 indexed citations
7.
Ibrahim, Ashraf S., Guanpingsheng Luo, Teclegiorgis Gebremariam, et al.. (2013). NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response. Vaccine. 31(47). 5549–5556. 73 indexed citations
8.
Schmidt, Clint S., C. J. White, Ashraf S. Ibrahim, et al.. (2012). NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults. Vaccine. 30(52). 7594–7600. 170 indexed citations
9.
Na, Songqing, Yanfei Ma, Jingyong Zhao, et al.. (2011). A Nonsecosteroidal Vitamin D Receptor Modulator Ameliorates Experimental Autoimmune Encephalomyelitis without Causing Hypercalcemia. Autoimmune Diseases. 2011. 1–14. 16 indexed citations
10.
Holtmeier, Wolfgang, Stefan Zeuzem, J. Preiß, et al.. (2010). A randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohns disease: Good safety profile but lack of efficacy. Zeitschrift für Gastroenterologie. 48(8). 15 indexed citations
11.
Schmidt, Clint S., W J Morrow, & Nadeem A. Sheikh. (2007). Smart adjuvants. Expert Review of Vaccines. 6(3). 391–400. 27 indexed citations
12.
Schmidt, Clint S., Jingyong Zhao, Deena L. Hepburn, et al.. (2005). Resistance to Myelin Oligodendrocyte Glycoprotein-Induced Experimental Autoimmune Encephalomyelitis by Death Receptor 6-Deficient Mice. The Journal of Immunology. 175(4). 2286–2292. 17 indexed citations
13.
Liu, Jinqi, Clint S. Schmidt, Angela J. Okragly, et al.. (2003). LIGHT‐deficiency impairs CD8+ T cell expansion, but not effector function. International Immunology. 15(7). 861–870. 33 indexed citations
14.
Schmidt, Clint S. & Matthew F. Mescher. (2002). Peptide Antigen Priming of Naive, But Not Memory, CD8 T Cells Requires a Third Signal That Can Be Provided by IL-12. The Journal of Immunology. 168(11). 5521–5529. 110 indexed citations
15.
Ingulli, Elizabeth, Julie Curtsinger, Clint S. Schmidt, et al.. (2002). The Adjuvant Effects of Mycobacterium tuberculosis Heat Shock Protein 70 Result from the Rapid and Prolonged Activation of Antigen-Specific CD8+ T Cells In Vivo. The Journal of Immunology. 169(10). 5622–5629. 46 indexed citations
16.
Schmidt, Clint S., Jinqi Liu, Ho Yeong Song, et al.. (2002). Enhanced B Cell Expansion, Survival, and Humoral Responses by Targeting Death Receptor 6. The Journal of Experimental Medicine. 197(1). 51–62. 36 indexed citations
17.
Kieper, William C., Martin Prlic, Clint S. Schmidt, Matthew F. Mescher, & Stephen C. Jameson. (2001). IL-12 Enhances CD8 T Cell Homeostatic Expansion. The Journal of Immunology. 166(9). 5515–5521. 99 indexed citations
18.
Curtsinger, Julie, Clint S. Schmidt, Anna Mondino, et al.. (1999). Inflammatory Cytokines Provide a Third Signal for Activation of Naive CD4+ and CD8+ T Cells. The Journal of Immunology. 162(6). 3256–3262. 471 indexed citations
19.
Hasche, H, et al.. (1999). Effects of acarbose treatment in Type 2 diabetic patients under dietary training: a multicentre, double-blind, placebo-controlled, 2-year study.. PubMed. 12(4). 277–85. 30 indexed citations
20.
Schmidt, Clint S. & Matthew F. Mescher. (1999). Adjuvant Effect of IL-12: Conversion of Peptide Antigen Administration from Tolerizing to Immunizing for CD8+ T Cells In Vivo. The Journal of Immunology. 163(5). 2561–2567. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026